Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.08
-0.27 (-4.25%)
At close: Nov 16, 2026, 4:00 PM EST
6.19
+0.11 (1.81%)
After-hours: Nov 16, 2026, 7:33 PM EST

Cartesian Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
122.98125.14212.6176.91106.444.74
Short-Term Investments
----28.16-
Cash & Short-Term Investments
122.98125.14212.6176.91134.64.74
Cash Growth
-14.23%-41.14%176.44%-42.86%2742.70%-
Accounts Receivable
0.051.120.878.859.763.13
Other Receivables
-----0.23
Receivables
0.051.120.878.859.763.35
Prepaid Expenses
8.473.023.144.973.490.05
Restricted Cash
----0.29-
Total Current Assets
131.5129.28216.6390.73148.148.14
Property, Plant & Equipment
15.6117.7915.4512.1814.411.5
Long-Term Investments
--222-
Goodwill
48.1648.1648.1648.16--
Other Intangible Assets
93.993.9150.6150.6--
Other Long-Term Assets
5.137.292.191.381.340.03
Total Assets
294.31296.41435.02305.05165.899.67

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.111.290.293.150.32-
Accrued Expenses
10.959.1611.2414.6114.080.79
Current Portion of Long-Term Debt
----8.48-
Current Portion of Leases
4.214.152.852.171.610.17
Current Unearned Revenue
---2.310.590.12
Other Current Liabilities
0.430.348.645.98-0.19
Total Current Liabilities
15.714.9422.9868.2125.081.27
Long-Term Debt
50.22---17.79-
Long-Term Leases
5.918.5311.138.7910.061.11
Long-Term Unearned Revenue
---3.54--
Long-Term Deferred Tax Liabilities
6.956.9516.1415.85--
Other Long-Term Liabilities
346392.24391.58348.2919.140.35
Total Liabilities
424.77422.65441.83444.6872.062.72

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
00000.02-
Additional Paid-In Capital
731.41700.71689.89179.06493.316.64
Retained Earnings
-857.26-822.37-692.07-614.65-394.94-19.61
Comprehensive Income & Other
-4.62-4.58-4.62-4.6-4.56-
Total Common Equity
-130.47-126.24-6.8-440.1893.83-12.97
Shareholders' Equity
-130.47-126.24-6.8-139.6393.836.95
Total Liabilities & Equity
294.31296.41435.02305.05165.899.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
60.3412.6813.9810.9637.931.28
Net Cash (Debt)
62.64112.46198.6365.9696.683.46
Net Cash Growth
-52.10%-43.38%201.15%-31.78%2698.18%-
Net Cash Per Share
2.224.3311.4412.7619.880.91
Filing Date Shares Outstanding
30.526.5125.915.4-3.81
Total Common Shares Outstanding
30.4926.0125.775.4-3.81
Working Capital
115.8114.34193.6522.52123.066.87
Book Value Per Share
-4.28-4.85-0.26-81.55--
Tangible Book Value
-272.53-268.3-205.57-638.9593.83-12.97
Tangible Book Value Per Share
-8.94-10.31-7.98-118.38--
Machinery
10.429.288.157.637.340.78
Construction In Progress
0.393.470.70.150.6-
Leasehold Improvements
6.834.183.430.060.06-
SEC Filings: 10-K · 10-Q